Don Hayes1,2,3, Kaitlyn T Hayes4, Hunter C Hayes4, Joseph D Tobias5,6. 1. Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA. hayes.705@osu.edu. 2. Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA. hayes.705@osu.edu. 3. Section of Pulmonary Medicine, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. hayes.705@osu.edu. 4. Section of Pulmonary Medicine, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. 5. Department of Anesthesiology, The Ohio State University College of Medicine, Columbus, OH, USA. 6. Department of Anesthesiology & Pain Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Abstract
BACKGROUND: Survival after lung transplantation (LTx) for patients with occupational lung disease (OLD) is not well studied. METHODS: The United Network for Organ Sharing (UNOS) database was queried from 2005 to 2013 to assess survival after LTx in patients with silicosis and non-silicotic OLD compared to non-OLD patients. RESULTS: Of 7273 adult LTx recipients, 7227 (24 with silicosis and 29 with non-silicotic OLD) were included in our univariate and Kaplan-Meier function analysis and 6370 for multivariate Cox models. Univariate Cox models did not identify survival differences in silicosis (HR 0.717; 95 % CI 0.358-1.435; p = 0.347) and non-silicotic OLDs (HR 0.934; 95 % CI 0.486-1.798; p = 0.839). Kaplan-Meier function analysis did not identify a survival disadvantage for either silicosis or non-silicotic OLD (log-rank test: χ (2) 0.93, p = 0.627). Patients with non-silicotic OLD were at risk for worse survival for the first 2.5 years post-transplant; however, at the conclusion of the study, this group had the highest survival rate. Multivariate Cox models confirmed no increased risk for mortality for silicosis (HR 1.264; 95 % CI 0.631-2.534; p = 0.509) and non-silicotic OLD (HR 1.114; 95 % CI 0.578-2.147; p = 0.747). CONCLUSION: Long-term survival for adult patients with silicosis and non-silicotic OLD after LTx is not significantly different compared to the general lung transplant population.
BACKGROUND: Survival after lung transplantation (LTx) for patients with occupational lung disease (OLD) is not well studied. METHODS: The United Network for Organ Sharing (UNOS) database was queried from 2005 to 2013 to assess survival after LTx in patients with silicosis and non-silicotic OLD compared to non-OLD patients. RESULTS: Of 7273 adult LTx recipients, 7227 (24 with silicosis and 29 with non-silicotic OLD) were included in our univariate and Kaplan-Meier function analysis and 6370 for multivariate Cox models. Univariate Cox models did not identify survival differences in silicosis (HR 0.717; 95 % CI 0.358-1.435; p = 0.347) and non-silicotic OLDs (HR 0.934; 95 % CI 0.486-1.798; p = 0.839). Kaplan-Meier function analysis did not identify a survival disadvantage for either silicosis or non-silicotic OLD (log-rank test: χ (2) 0.93, p = 0.627). Patients with non-silicotic OLD were at risk for worse survival for the first 2.5 years post-transplant; however, at the conclusion of the study, this group had the highest survival rate. Multivariate Cox models confirmed no increased risk for mortality for silicosis (HR 1.264; 95 % CI 0.631-2.534; p = 0.509) and non-silicotic OLD (HR 1.114; 95 % CI 0.578-2.147; p = 0.747). CONCLUSION: Long-term survival for adult patients with silicosis and non-silicotic OLD after LTx is not significantly different compared to the general lung transplant population.
Authors: Don Hayes; Enrique Diaz-Guzman; Daniel L Davenport; Joseph B Zwischenberger; Mehdi Khosravi; Kimberly J Absher; Charles W Hoopes Journal: Clin Transplant Date: 2012-02-23 Impact factor: 2.863
Authors: Kyle B Enfield; Shawn Floyd; Billie Barker; Max Weder; Benjamin D Kozower; David R Jones; Christine L Lau Journal: J Heart Lung Transplant Date: 2012-10-11 Impact factor: 10.247
Authors: Roger D Yusen; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Fabienne Dobbels; Samuel B Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Josef Stehlik Journal: J Heart Lung Transplant Date: 2014-08-14 Impact factor: 10.247
Authors: F Derom; F Barbier; S Ringoir; J Versieck; G Rolly; G Berzsenyi; P Vermeire; L Vrints Journal: J Thorac Cardiovasc Surg Date: 1971-06 Impact factor: 5.209
Authors: Jeremiah G Allen; Eric S Weiss; Christian A Merlo; William A Baumgartner; John V Conte; Ashish S Shah Journal: J Heart Lung Transplant Date: 2009-10 Impact factor: 10.247
Authors: David J Blackley; Cara N Halldin; Robert A Cohen; Kristin J Cummings; Eileen Storey; A Scott Laney Journal: J Heart Lung Transplant Date: 2017-02-24 Impact factor: 10.247
Authors: Fabiola Adélia Perin; Stephan Altmayer; Douglas Zaione Nascimento; Guilherme Moreira-Hetzel; Spencer Marcantonio Camargo; Bruno Hochhegger; Luziélio Alves Sidney Filho; José de Jesus Camargo; Guilherme Watte Journal: J Bras Pneumol Date: 2022-04-20 Impact factor: 2.800